Bicine

Bicine

SCHEMBL783494

O=C([O-])CN(CCO)CCO.[Na+]

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Bicine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA4 known ✓ P22748 3/20 0.36
ACE known ✓ P12821 1/20 0.32
CA1 known ✓ P00915 1/20 0.30
CA2 known ✓ P00918 1/20 0.30
KDM4E B2RXH2 2/20 0.91
ALOX15 P16050 2/20 0.91
MAPT P10636 1/20 0.91
SMN1; SMN2 Q16637 1/20 0.91
TDP1 Q9NUW8 2/20 0.36
LMNA P02545 1/20 0.36
CHRM2 P08172 1/20 0.36
ADRA2A P08913 1/20 0.36
TSHR P16473 1/20 0.36
DRD1 P21728 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
CYP2C19 P33261 1/20 0.36
ADRA1A P35348 1/20 0.36
DRD3 P35462 1/20 0.36
BLM P54132 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31349875 0.97 KDM4E (0.95) KDM4EALOX15MAPTSMN1; SMN2CA4
SCHEMBL379765 0.95 ALOX15 (1.00) KDM4EALOX15MAPTSMN1; SMN2CA4
Bicine SCHEMBL30342023 0.95 KDM4E (0.82) KDM4EALOX15MAPTSMN1; SMN2CA4
SCHEMBL382697 0.95 ALOX15 (0.91) KDM4EALOX15MAPTSMN1; SMN2CA4
Bicine SCHEMBL3981661 0.95 KDM4E (0.82) KDM4EALOX15MAPTSMN1; SMN2CA4
Bicine SCHEMBL5065709 0.95 KDM4E (0.82) KDM4EALOX15MAPTSMN1; SMN2CA4
Water SCHEMBL9900448 0.93 KDM4E (0.95) KDM4EALOX15MAPTSMN1; SMN2CA4
Water SCHEMBL10767426 0.93 KDM4E (0.95) KDM4EALOX15MAPTSMN1; SMN2CA4
Water SCHEMBL11884555 0.92 ALOX15 (0.86) KDM4EALOX15MAPTSMN1; SMN2CA4
SCHEMBL8948288 0.91 KDM4E (0.76) KDM4EALOX15MAPTSMN1; SMN2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 281 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200181480-A1 ALKYL POLYGLYCOSIDE SURFACTANTS FOR USE IN SUBTERRANEAN FORMATIONS HALLIBURTON ENERGY SERVICES, INC. 2020-06-11 US claimed
US-10329859-B2 Alkylpolyglucoside derivative fluid loss control additives for wellbore treatment fluids HALLIBURTON ENERGY SERVICES, INC. (US) 2019-06-25 US claimed
US-20190099342-A1 COOLING PRODUCT SYMRISE AG (DE) 2019-04-04 US claimed
US-10106719-B2 Alkyl polyglycoside derivative as biodegradable foaming surfactant for cement HALLIBURTON ENERGY SERVICES, INC. (US) 2018-10-23 US claimed
US-20180282610-A1 ALKYL POLYGLYCOSIDE SURFACTANTS FOR USE IN SUBTERRANEAN FORMATIONS MULTI-CHEM GROUP, LLC 2018-10-04 US claimed
US-20180086965-A1 ALKYLPOLYGLUCOSIDE DERIVATIVE FLUID LOSS CONTROL ADDITIVES FOR WELLBORE TREATMENT FLUIDS HALLIBURTON ENERGY SERVICES, INC. 2018-03-29 US claimed
EP-2925829-B1 ALKYL POLYGLYCOSIDE DERIVATIVE AS BIODEGRADABLE FOAMING SURFACTANT FOR CEMENT HALLIBURTON ENERGY SERVICES INC (US) 2017-08-30 EP claimed
US-9701886-B2 Alkyl polyglycoside derivative as biodegradable foaming surfactant for cement HALLIBURTON ENERGY SERVICES, INC. (US) 2017-07-11 US claimed
US-20170183557-A1 ALKYL POLYGLYCOSIDE DERIVATIVE AS BIODEGRADABLE FOAMING SURFACTANT FOR CEMENT HALLIBURTON ENERGY SERVICES, INC. 2017-06-29 US claimed
EP-3078365-A1 SOLUBILIZING AGENTS AND AQUEOUS COMPOSITIONS COMPRISING THEM Daito Kasei Industries France (FR) 2016-10-12 EP claimed
EP-2964720-A1 ALKYL POLYGLYCOSIDE DERIVATIVE AS BIODEGRADABLE SPACER SURFACTANT HALLIBURTON ENERGY SERVICES, INC. (US) 2016-01-13 EP claimed
EP-2925829-A1 ALKYL POLYGLYCOSIDE DERIVATIVE AS BIODEGRADABLE FOAMING SURFACTANT FOR CEMENT Halliburton Energy Services, Inc. (US) 2015-10-07 EP claimed
US-20150184057-A1 Alkyl Polyglycoside Derivative as Biodegradable Spacer Surfactant HALLIBURTON ENERGY SERVICES, INC. 2015-07-02 US claimed
WO-2014137455-A1 ALKYL POLYGLYCOSIDE DERIVATIVE AS BIODEGRADABLE FOAMING SURFACTANT FOR CEMENT HALLIBURTON ENERGY SERVICES, INC. (US) 2014-09-12 WO claimed
WO-2014137494-A1 ALKYL POLYGLYCOSIDE DERIVATIVE AS BIODEGRADABLE SPACER SURFACTANT HALLIBURTON ENERGY SERVICES, INC. (US) 2014-09-12 WO claimed
US-20140256603-A1 Alkyl Polyglycoside Derivative as Biodegradable Spacer Surfactant HALLIBURTON ENERGY SERVICES, INC. (US) 2014-09-11 US claimed
US-20140251614-A1 Alkyl Polyglycoside Derivative as Biodegradable Foaming Surfactant for Cement HALLIBURTON ENERGY SERVICES, INC. (US) 2014-09-11 US claimed
US-5585391-A Hydroxyl ions as unique therapeutic agents and compounds that modulate these ions, compositions employing these agents, therapeutic methods for using such agents and processes for preparing them FHJ SCIENTIFIC, INC. (US) 1996-12-17 US claimed
EP-0725636-A1 HYDROXYL IONS AS UNIQUE THERAPEUTIC AGENTS AND COMPOUNDS THAT MODULATE THESE IONS, COMPOSITIONS EMPLOYING THESE AGENTS, THERAPEUTIC METHODS FOR USING SUCH AGENTS AND PROCESSES FOR PREPARING THEM FHJ SCIENTIFIC, INC. (US) 1996-08-14 EP claimed
WO-1995010272-A1 HYDROXYL IONS AS UNIQUE THERAPEUTIC AGENTS AND COMPOUNDS THAT MODULATE THESE IONS, COMPOSITIONS EMPLOYING THESE AGENTS, THERAPEUTIC METHODS FOR USING SUCH AGENTS AND PROCESSES FOR PREPARING THEM FHJ SCIENTIFIC, INC. (US) 1995-04-20 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190099342-A1 COOLING PRODUCT TRPA1, TRPV2, NISCH CA4 975/4885ACE 977/4885CA1 2904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.